経口吸入ジェネリック医薬品の世界市場に関する洞察、2030年までの予測

当レポートは、経口吸入ジェネリック医薬品 (Orally Inhaled Generic Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• 経口吸入ジェネリック医薬品の製品概要
• 市場：タイプ別
  • 世界の経口吸入ジェネリック医薬品の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
  • DPI
  • MDI
  • NEB
• 市場：用途別
  • 世界の経口吸入ジェネリック医薬品の市場規模成長率：用途別, 2019 VS 2023 VS 2030
  • Asthma
  • COPD
  • Inhalation Anesthesia
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界の経口吸入ジェネリック医薬品の収益 推定および予測 2019-2030
• 世界の経口吸入ジェネリック医薬品の収益：地域別
  • 世界の経口吸入ジェネリック医薬品の収益：地域別: 2019 VS 2023 VS 2030
  • 世界の経口吸入ジェネリック医薬品の収益：地域別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の収益：地域別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の収益市場シェア 地域別 (2019-2030)
• 世界の経口吸入ジェネリック医薬品 売上予測・予想 2019-2030
• 世界の経口吸入ジェネリック医薬品の販売：地域別
  • 世界の経口吸入ジェネリック医薬品の販売：地域別: 2019 VS 2023 VS 2030
  • 世界の経口吸入ジェネリック医薬品の販売：地域別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の販売：地域別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の販売市場シェア 地域別 (2019-2030)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界の経口吸入ジェネリック医薬品の販売：企業別
  • 世界の経口吸入ジェネリック医薬品の販売：企業別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の販売市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： 経口吸入ジェネリック医薬品 in 2023
• 世界の経口吸入ジェネリック医薬品の収益：企業別
  • 世界の経口吸入ジェネリック医薬品の収益：企業別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の収益市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： 経口吸入ジェネリック医薬品の収益 2023
• 世界の主要企業 経口吸入ジェネリック医薬品, 業界ランキング, 2021 VS 2022
• 世界の経口吸入ジェネリック医薬品の販売価格：企業別 (2019-2024)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界の経口吸入ジェネリック医薬品の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー 経口吸入ジェネリック医薬品, 製造拠点分布と本社
• 世界の主要メーカー 経口吸入ジェネリック医薬品, 提供製品と用途
• 世界の主要メーカー 経口吸入ジェネリック医薬品, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界の経口吸入ジェネリック医薬品の販売：タイプ別
  • 世界の経口吸入ジェネリック医薬品の販売実績：タイプ別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の販売予測：タイプ別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の販売市場シェア：タイプ別 (2019-2030)
• 世界の経口吸入ジェネリック医薬品 収益：タイプ別
  • 世界の経口吸入ジェネリック医薬品の収益実績：タイプ別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の収益予測：タイプ別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の収益市場シェア：タイプ別 (2019-2030)
• 世界の経口吸入ジェネリック医薬品の価格：タイプ別
  • 世界の経口吸入ジェネリック医薬品の価格：タイプ別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

• 世界の経口吸入ジェネリック医薬品の販売：用途別
  • 世界の経口吸入ジェネリック医薬品の販売実績：用途別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の販売予測：用途別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の販売市場シェア：用途別 (2019-2030)
• 世界の経口吸入ジェネリック医薬品の収益：用途別
  • 世界の経口吸入ジェネリック医薬品の収益実績：用途別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の収益予測：用途別 (2025-2030)
  • 世界の経口吸入ジェネリック医薬品の収益市場シェア：用途別 (2019-2030)
• 世界の経口吸入ジェネリック医薬品の価格：用途別
  • 世界の経口吸入ジェネリック医薬品の価格：用途別 (2019-2024)
  • 世界の経口吸入ジェネリック医薬品の価格予測：用途別 (2025-2030)

第6章 米国・カナダ

• 米国・カナダ 経口吸入ジェネリック医薬品 市場規模：タイプ別
  • 米国・カナダ 経口吸入ジェネリック医薬品の販売：タイプ別 (2019-2030)
  • 米国・カナダ 経口吸入ジェネリック医薬品 収益：タイプ別 (2019-2030)
• 米国・カナダ 経口吸入ジェネリック医薬品 市場規模：用途別
  • 米国・カナダ 経口吸入ジェネリック医薬品の販売：用途別 (2019-2030)
  • 米国・カナダ 経口吸入ジェネリック医薬品の収益：用途別 (2019-2030)
• 米国・カナダ 経口吸入ジェネリック医薬品 市場規模：国別
  • 米国・カナダ 経口吸入ジェネリック医薬品の収益：国別: 2019 VS 2023 VS 2030
  • 米国・カナダ 経口吸入ジェネリック医薬品の収益：国別 (2019-2030)
  • 米国・カナダ 経口吸入ジェネリック医薬品の販売：国別 (2019-2030)
  • US
  • カナダ

第7章 欧州

• 欧州の経口吸入ジェネリック医薬品 市場規模：タイプ別
  • 欧州の経口吸入ジェネリック医薬品の販売：タイプ別 (2019-2030)
  • 欧州の経口吸入ジェネリック医薬品 収益：タイプ別 (2019-2030)
• 欧州の経口吸入ジェネリック医薬品 市場規模：用途別
  • 欧州の経口吸入ジェネリック医薬品の販売：用途別 (2019-2030)
  • 欧州の経口吸入ジェネリック医薬品の収益：用途別 (2019-2030)
• 欧州の経口吸入ジェネリック医薬品 市場規模：国別
  • 欧州の経口吸入ジェネリック医薬品の収益：国別: 2019 VS 2023 VS 2030
  • 欧州の経口吸入ジェネリック医薬品の収益：国別 (2019-2030)
  • 欧州の経口吸入ジェネリック医薬品の販売：国別 (2019-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国の経口吸入ジェネリック医薬品 市場規模：タイプ別
  • 中国の経口吸入ジェネリック医薬品の販売：タイプ別 (2019-2030)
  • 中国の経口吸入ジェネリック医薬品 収益：タイプ別 (2019-2030)
• 中国の経口吸入ジェネリック医薬品 市場規模：用途別
  • 中国の経口吸入ジェネリック医薬品の販売：用途別 (2019-2030)
  • 中国の経口吸入ジェネリック医薬品の収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 経口吸入ジェネリック医薬品 市場規模：タイプ別
  • アジア地域 経口吸入ジェネリック医薬品の販売：タイプ別 (2019-2030)
  • アジア地域 経口吸入ジェネリック医薬品 収益：タイプ別 (2019-2030)
• アジア地域 経口吸入ジェネリック医薬品 市場規模：用途別
  • アジア地域 経口吸入ジェネリック医薬品の販売：用途別 (2019-2030)
  • アジア地域 経口吸入ジェネリック医薬品の収益：用途別 (2019-2030)
• アジア地域 経口吸入ジェネリック医薬品 市場規模：地域別
  • アジア地域 経口吸入ジェネリック医薬品の収益：地域別: 2019 VS 2023 VS 2030
  • アジア地域 経口吸入ジェネリック医薬品の収益：地域別 (2019-2030)
  • アジア地域 経口吸入ジェネリック医薬品の販売：地域別 (2019-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品 市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の販売：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品 収益：タイプ別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品 市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の販売：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の収益：用途別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品 市場規模：国別
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の収益：国別: 2019 VS 2023 VS 2030
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の収益：国別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカの経口吸入ジェネリック医薬品の販売：国別 (2019-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• GSK
• AstraZeneca
• Boehringer-Ingelheim
• CTTQ
• Sphsine
• Daphne Pharmaceutical
• Jewim Pharmaceutical
• CF PharmTech
• Xianju Pharmaceutical
• Joincare Pharmaceutical
• Hengrui Medicine
• Purity Pharmaceutical

第12章 業界チェーンと販売チャネルの分析

• 経口吸入ジェネリック医薬品 業界チェーン分析
• 経口吸入ジェネリック医薬品 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• 経口吸入ジェネリック医薬品 生産形態とプロセス
• 経口吸入ジェネリック医薬品 販売およびマーケティング
  • 経口吸入ジェネリック医薬品 販売チャネルs
  • 経口吸入ジェネリック医薬品 卸業者
• 経口吸入ジェネリック医薬品 顧客

第13章 経口吸入ジェネリック医薬品 市場動向

• 経口吸入ジェネリック医薬品 業界動向
• 経口吸入ジェネリック医薬品 市場の促進要因
• 経口吸入ジェネリック医薬品 市場の課題
• 経口吸入ジェネリック医薬品 市場の抑制要因

第14章 主な調査結果 世界の経口吸入ジェネリック医薬品の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Orally Inhaled Generic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of DPI

Table 3. Major Manufacturers of MDI

Table 4. Major Manufacturers of NEB

Table 5. Global Orally Inhaled Generic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Orally Inhaled Generic Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Orally Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Orally Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2019-2024)

Table 10. Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2025-2030)

Table 11. Global Orally Inhaled Generic Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 12. Global Orally Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)

Table 13. Global Orally Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)

Table 14. Global Orally Inhaled Generic Drugs Sales Market Share by Region (2019-2024)

Table 15. Global Orally Inhaled Generic Drugs Sales Market Share by Region (2025-2030)

Table 16. Global Orally Inhaled Generic Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 17. Global Orally Inhaled Generic Drugs Sales Share by Manufacturers (2019-2024)

Table 18. Global Orally Inhaled Generic Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Orally Inhaled Generic Drugs Revenue Market Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Orally Inhaled Generic Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 21. Orally Inhaled Generic Drugs Price by Manufacturers (2019-2024) & (US$/Unit)

Table 22. Global Orally Inhaled Generic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Orally Inhaled Generic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Inhaled Generic Drugs as of 2023)

Table 24. Global Key Manufacturers of Orally Inhaled Generic Drugs, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Orally Inhaled Generic Drugs, Product Offered and Application

Table 26. Global Key Manufacturers of Orally Inhaled Generic Drugs, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 29. Global Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 30. Global Orally Inhaled Generic Drugs Sales Share by Type (2019-2024)

Table 31. Global Orally Inhaled Generic Drugs Sales Share by Type (2025-2030)

Table 32. Global Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Orally Inhaled Generic Drugs Revenue Share by Type (2019-2024)

Table 35. Global Orally Inhaled Generic Drugs Revenue Share by Type (2025-2030)

Table 36. Orally Inhaled Generic Drugs Price by Type (2019-2024) & (US$/Unit)

Table 37. Global Orally Inhaled Generic Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 38. Global Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 39. Global Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 40. Global Orally Inhaled Generic Drugs Sales Share by Application (2019-2024)

Table 41. Global Orally Inhaled Generic Drugs Sales Share by Application (2025-2030)

Table 42. Global Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Orally Inhaled Generic Drugs Revenue Share by Application (2019-2024)

Table 45. Global Orally Inhaled Generic Drugs Revenue Share by Application (2025-2030)

Table 46. Orally Inhaled Generic Drugs Price by Application (2019-2024) & (US$/Unit)

Table 47. Global Orally Inhaled Generic Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 48. US & Canada Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 49. US & Canada Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 50. US & Canada Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 53. US & Canada Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 54. US & Canada Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Orally Inhaled Generic Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 60. US & Canada Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 61. Europe Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 62. Europe Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 63. Europe Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 66. Europe Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 67. Europe Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Orally Inhaled Generic Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 73. Europe Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 74. China Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 75. China Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 76. China Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 79. China Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 80. China Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 83. Asia Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 84. Asia Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 87. Asia Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 88. Asia Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Orally Inhaled Generic Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Orally Inhaled Generic Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Orally Inhaled Generic Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Orally Inhaled Generic Drugs Sales by Region (2019-2024) & (K Units)

Table 94. Asia Orally Inhaled Generic Drugs Sales by Region (2025-2030) & (K Units)

Table 95. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Type (2019-2024) & (K Units)

Table 96. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Type (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Application (2019-2024) & (K Units)

Table 100. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Application (2025-2030) & (K Units)

Table 101. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Country (2019-2024) & (K Units)

Table 107. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Country (2025-2030) & (K Units)

Table 108. GSK Company Information

Table 109. GSK Description and Major Businesses

Table 110. GSK Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 111. GSK Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. GSK Recent Developments

Table 113. AstraZeneca Company Information

Table 114. AstraZeneca Description and Major Businesses

Table 115. AstraZeneca Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 116. AstraZeneca Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. AstraZeneca Recent Developments

Table 118. Boehringer-Ingelheim Company Information

Table 119. Boehringer-Ingelheim Description and Major Businesses

Table 120. Boehringer-Ingelheim Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 121. Boehringer-Ingelheim Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Boehringer-Ingelheim Recent Developments

Table 123. CTTQ Company Information

Table 124. CTTQ Description and Major Businesses

Table 125. CTTQ Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 126. CTTQ Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. CTTQ Recent Developments

Table 128. Sphsine Company Information

Table 129. Sphsine Description and Major Businesses

Table 130. Sphsine Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 131. Sphsine Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Sphsine Recent Developments

Table 133. Daphne Pharmaceutical Company Information

Table 134. Daphne Pharmaceutical Description and Major Businesses

Table 135. Daphne Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 136. Daphne Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Daphne Pharmaceutical Recent Developments

Table 138. Jewim Pharmaceutical Company Information

Table 139. Jewim Pharmaceutical Description and Major Businesses

Table 140. Jewim Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 141. Jewim Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Jewim Pharmaceutical Recent Developments

Table 143. CF PharmTech Company Information

Table 144. CF PharmTech Description and Major Businesses

Table 145. CF PharmTech Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 146. CF PharmTech Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. CF PharmTech Recent Developments

Table 148. Xianju Pharmaceutical Company Information

Table 149. Xianju Pharmaceutical Description and Major Businesses

Table 150. Xianju Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 151. Xianju Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Xianju Pharmaceutical Recent Developments

Table 153. Joincare Pharmaceutical Company Information

Table 154. Joincare Pharmaceutical Description and Major Businesses

Table 155. Joincare Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 156. Joincare Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Joincare Pharmaceutical Recent Developments

Table 158. Hengrui Medicine Company Information

Table 159. Hengrui Medicine Description and Major Businesses

Table 160. Hengrui Medicine Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 161. Hengrui Medicine Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Hengrui Medicine Recent Developments

Table 163. Purity Pharmaceutical Company Information

Table 164. Purity Pharmaceutical Description and Major Businesses

Table 165. Purity Pharmaceutical Orally Inhaled Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 166. Purity Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Purity Pharmaceutical Recent Developments

Table 168. Key Raw Materials Lists

Table 169. Raw Materials Key Suppliers Lists

Table 170. Orally Inhaled Generic Drugs Distributors List

Table 171. Orally Inhaled Generic Drugs Customers List

Table 172. Orally Inhaled Generic Drugs Market Trends

Table 173. Orally Inhaled Generic Drugs Market Drivers

Table 174. Orally Inhaled Generic Drugs Market Challenges

Table 175. Orally Inhaled Generic Drugs Market Restraints

Table 176. Research Programs/Design for This Report

Table 177. Key Data Information from Secondary Sources

Table 178. Key Data Information from Primary Sources

List of Figures

Figure 1. Orally Inhaled Generic Drugs Product Picture

Figure 2. Global Orally Inhaled Generic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Orally Inhaled Generic Drugs Market Share by Type: 2023 & 2030

Figure 4. DPI Product Picture

Figure 5. MDI Product Picture

Figure 6. NEB Product Picture

Figure 7. Global Orally Inhaled Generic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Orally Inhaled Generic Drugs Market Share by Application: 2023 & 2030

Figure 9. Asthma

Figure 10. COPD

Figure 11. Inhalation Anesthesia

Figure 12. Others

Figure 13. Orally Inhaled Generic Drugs Report Years Considered

Figure 14. Global Orally Inhaled Generic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 16. Global Orally Inhaled Generic Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 17. Global Orally Inhaled Generic Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2019-2030)

Figure 19. Global Orally Inhaled Generic Drugs Sales (2019-2030) & (K Units)

Figure 20. Global Orally Inhaled Generic Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 21. Global Orally Inhaled Generic Drugs Sales Market Share by Region (2019-2030)

Figure 22. US & Canada Orally Inhaled Generic Drugs Sales YoY (2019-2030) & (K Units)

Figure 23. US & Canada Orally Inhaled Generic Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Europe Orally Inhaled Generic Drugs Sales YoY (2019-2030) & (K Units)

Figure 25. Europe Orally Inhaled Generic Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. China Orally Inhaled Generic Drugs Sales YoY (2019-2030) & (K Units)

Figure 27. China Orally Inhaled Generic Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Asia (excluding China) Orally Inhaled Generic Drugs Sales YoY (2019-2030) & (K Units)

Figure 29. Asia (excluding China) Orally Inhaled Generic Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales YoY (2019-2030) & (K Units)

Figure 31. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 32. Global Orally Inhaled Generic Drugs Sales Share by Manufacturers (2023)

Figure 33. The Orally Inhaled Generic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 34. Global Orally Inhaled Generic Drugs Revenue Share by Manufacturers (2023)

Figure 35. The Top 5 and 10 Largest Manufacturers of Orally Inhaled Generic Drugs in the World: Market Share by Orally Inhaled Generic Drugs Revenue in 2023

Figure 36. Global Orally Inhaled Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 37. Global Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 38. Global Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 39. Global Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 40. Global Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 41. US & Canada Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 42. US & Canada Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 43. US & Canada Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 44. US & Canada Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 45. US & Canada Orally Inhaled Generic Drugs Revenue Share by Country (2019-2030)

Figure 46. US & Canada Orally Inhaled Generic Drugs Sales Share by Country (2019-2030)

Figure 47. US Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 48. Canada Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 49. Europe Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 50. Europe Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 51. Europe Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 52. Europe Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 53. Europe Orally Inhaled Generic Drugs Revenue Share by Country (2019-2030)

Figure 54. Europe Orally Inhaled Generic Drugs Sales Share by Country (2019-2030)

Figure 55. Germany Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. France Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. U.K. Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. Italy Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 59. Russia Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 60. China Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 61. China Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 62. China Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 63. China Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 64. Asia Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 65. Asia Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 66. Asia Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 67. Asia Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 68. Asia Orally Inhaled Generic Drugs Revenue Share by Region (2019-2030)

Figure 69. Asia Orally Inhaled Generic Drugs Sales Share by Region (2019-2030)

Figure 70. Japan Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. South Korea Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. China Taiwan Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. Southeast Asia Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. India Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 75. Australia Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 76. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)

Figure 77. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)

Figure 78. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)

Figure 79. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)

Figure 80. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue Share by Country (2019-2030)

Figure 81. Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales Share by Country (2019-2030)

Figure 82. Brazil Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Mexico Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. Turkey Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Israel Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 86. GCC Countries Orally Inhaled Generic Drugs Revenue (2019-2030) & (US$ Million)

Figure 87. Orally Inhaled Generic Drugs Value Chain

Figure 88. Orally Inhaled Generic Drugs Production Process

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

This research report focuses on the Orally Inhaled Generic Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Orally Inhaled Generic Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Orally Inhaled Generic Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 DPI
  • 1.2.3 MDI
  • 1.2.4 NEB
• 1.3 Market by Application
  • 1.3.1 Global Orally Inhaled Generic Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Asthma
  • 1.3.3 COPD
  • 1.3.4 Inhalation Anesthesia
  • 1.3.5 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Orally Inhaled Generic Drugs Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Orally Inhaled Generic Drugs Revenue by Region
  • 2.2.1 Global Orally Inhaled Generic Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Orally Inhaled Generic Drugs Revenue by Region (2019-2024)
  • 2.2.3 Global Orally Inhaled Generic Drugs Revenue by Region (2025-2030)
  • 2.2.4 Global Orally Inhaled Generic Drugs Revenue Market Share by Region (2019-2030)
• 2.3 Global Orally Inhaled Generic Drugs Sales Estimates and Forecasts 2019-2030
• 2.4 Global Orally Inhaled Generic Drugs Sales by Region
  • 2.4.1 Global Orally Inhaled Generic Drugs Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Orally Inhaled Generic Drugs Sales by Region (2019-2024)
  • 2.4.3 Global Orally Inhaled Generic Drugs Sales by Region (2025-2030)
  • 2.4.4 Global Orally Inhaled Generic Drugs Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Orally Inhaled Generic Drugs Sales by Manufacturers
  • 3.1.1 Global Orally Inhaled Generic Drugs Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Orally Inhaled Generic Drugs Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orally Inhaled Generic Drugs in 2023
• 3.2 Global Orally Inhaled Generic Drugs Revenue by Manufacturers
  • 3.2.1 Global Orally Inhaled Generic Drugs Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Orally Inhaled Generic Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Orally Inhaled Generic Drugs Revenue in 2023
• 3.3 Global Key Players of Orally Inhaled Generic Drugs, Industry Ranking, 2021 VS 2022
• 3.4 Global Orally Inhaled Generic Drugs Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Orally Inhaled Generic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Orally Inhaled Generic Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Orally Inhaled Generic Drugs, Product Offered and Application
• 3.8 Global Key Manufacturers of Orally Inhaled Generic Drugs, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Orally Inhaled Generic Drugs Sales by Type
  • 4.1.1 Global Orally Inhaled Generic Drugs Historical Sales by Type (2019-2024)
  • 4.1.2 Global Orally Inhaled Generic Drugs Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Orally Inhaled Generic Drugs Sales Market Share by Type (2019-2030)
• 4.2 Global Orally Inhaled Generic Drugs Revenue by Type
  • 4.2.1 Global Orally Inhaled Generic Drugs Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Orally Inhaled Generic Drugs Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Orally Inhaled Generic Drugs Revenue Market Share by Type (2019-2030)
• 4.3 Global Orally Inhaled Generic Drugs Price by Type
  • 4.3.1 Global Orally Inhaled Generic Drugs Price by Type (2019-2024)
  • 4.3.2 Global Orally Inhaled Generic Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Orally Inhaled Generic Drugs Sales by Application
  • 5.1.1 Global Orally Inhaled Generic Drugs Historical Sales by Application (2019-2024)
  • 5.1.2 Global Orally Inhaled Generic Drugs Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Orally Inhaled Generic Drugs Sales Market Share by Application (2019-2030)
• 5.2 Global Orally Inhaled Generic Drugs Revenue by Application
  • 5.2.1 Global Orally Inhaled Generic Drugs Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Orally Inhaled Generic Drugs Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Orally Inhaled Generic Drugs Revenue Market Share by Application (2019-2030)
• 5.3 Global Orally Inhaled Generic Drugs Price by Application
  • 5.3.1 Global Orally Inhaled Generic Drugs Price by Application (2019-2024)
  • 5.3.2 Global Orally Inhaled Generic Drugs Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Orally Inhaled Generic Drugs Market Size by Type
  • 6.1.1 US & Canada Orally Inhaled Generic Drugs Sales by Type (2019-2030)
  • 6.1.2 US & Canada Orally Inhaled Generic Drugs Revenue by Type (2019-2030)
• 6.2 US & Canada Orally Inhaled Generic Drugs Market Size by Application
  • 6.2.1 US & Canada Orally Inhaled Generic Drugs Sales by Application (2019-2030)
  • 6.2.2 US & Canada Orally Inhaled Generic Drugs Revenue by Application (2019-2030)
• 6.3 US & Canada Orally Inhaled Generic Drugs Market Size by Country
  • 6.3.1 US & Canada Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Orally Inhaled Generic Drugs Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Orally Inhaled Generic Drugs Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Orally Inhaled Generic Drugs Market Size by Type
  • 7.1.1 Europe Orally Inhaled Generic Drugs Sales by Type (2019-2030)
  • 7.1.2 Europe Orally Inhaled Generic Drugs Revenue by Type (2019-2030)
• 7.2 Europe Orally Inhaled Generic Drugs Market Size by Application
  • 7.2.1 Europe Orally Inhaled Generic Drugs Sales by Application (2019-2030)
  • 7.2.2 Europe Orally Inhaled Generic Drugs Revenue by Application (2019-2030)
• 7.3 Europe Orally Inhaled Generic Drugs Market Size by Country
  • 7.3.1 Europe Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Orally Inhaled Generic Drugs Revenue by Country (2019-2030)
  • 7.3.3 Europe Orally Inhaled Generic Drugs Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Orally Inhaled Generic Drugs Market Size by Type
  • 8.1.1 China Orally Inhaled Generic Drugs Sales by Type (2019-2030)
  • 8.1.2 China Orally Inhaled Generic Drugs Revenue by Type (2019-2030)
• 8.2 China Orally Inhaled Generic Drugs Market Size by Application
  • 8.2.1 China Orally Inhaled Generic Drugs Sales by Application (2019-2030)
  • 8.2.2 China Orally Inhaled Generic Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Orally Inhaled Generic Drugs Market Size by Type
  • 9.1.1 Asia Orally Inhaled Generic Drugs Sales by Type (2019-2030)
  • 9.1.2 Asia Orally Inhaled Generic Drugs Revenue by Type (2019-2030)
• 9.2 Asia Orally Inhaled Generic Drugs Market Size by Application
  • 9.2.1 Asia Orally Inhaled Generic Drugs Sales by Application (2019-2030)
  • 9.2.2 Asia Orally Inhaled Generic Drugs Revenue by Application (2019-2030)
• 9.3 Asia Orally Inhaled Generic Drugs Market Size by Region
  • 9.3.1 Asia Orally Inhaled Generic Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Orally Inhaled Generic Drugs Revenue by Region (2019-2030)
  • 9.3.3 Asia Orally Inhaled Generic Drugs Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Orally Inhaled Generic Drugs Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 GSK
  • 11.1.1 GSK Company Information
  • 11.1.2 GSK Overview
  • 11.1.3 GSK Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 GSK Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 GSK Recent Developments
• 11.2 AstraZeneca
  • 11.2.1 AstraZeneca Company Information
  • 11.2.2 AstraZeneca Overview
  • 11.2.3 AstraZeneca Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 AstraZeneca Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 AstraZeneca Recent Developments
• 11.3 Boehringer-Ingelheim
  • 11.3.1 Boehringer-Ingelheim Company Information
  • 11.3.2 Boehringer-Ingelheim Overview
  • 11.3.3 Boehringer-Ingelheim Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Boehringer-Ingelheim Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Boehringer-Ingelheim Recent Developments
• 11.4 CTTQ
  • 11.4.1 CTTQ Company Information
  • 11.4.2 CTTQ Overview
  • 11.4.3 CTTQ Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 CTTQ Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 CTTQ Recent Developments
• 11.5 Sphsine
  • 11.5.1 Sphsine Company Information
  • 11.5.2 Sphsine Overview
  • 11.5.3 Sphsine Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Sphsine Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Sphsine Recent Developments
• 11.6 Daphne Pharmaceutical
  • 11.6.1 Daphne Pharmaceutical Company Information
  • 11.6.2 Daphne Pharmaceutical Overview
  • 11.6.3 Daphne Pharmaceutical Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Daphne Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Daphne Pharmaceutical Recent Developments
• 11.7 Jewim Pharmaceutical
  • 11.7.1 Jewim Pharmaceutical Company Information
  • 11.7.2 Jewim Pharmaceutical Overview
  • 11.7.3 Jewim Pharmaceutical Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Jewim Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Jewim Pharmaceutical Recent Developments
• 11.8 CF PharmTech
  • 11.8.1 CF PharmTech Company Information
  • 11.8.2 CF PharmTech Overview
  • 11.8.3 CF PharmTech Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 CF PharmTech Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 CF PharmTech Recent Developments
• 11.9 Xianju Pharmaceutical
  • 11.9.1 Xianju Pharmaceutical Company Information
  • 11.9.2 Xianju Pharmaceutical Overview
  • 11.9.3 Xianju Pharmaceutical Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 Xianju Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 Xianju Pharmaceutical Recent Developments
• 11.10 Joincare Pharmaceutical
  • 11.10.1 Joincare Pharmaceutical Company Information
  • 11.10.2 Joincare Pharmaceutical Overview
  • 11.10.3 Joincare Pharmaceutical Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Joincare Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Joincare Pharmaceutical Recent Developments
• 11.11 Hengrui Medicine
  • 11.11.1 Hengrui Medicine Company Information
  • 11.11.2 Hengrui Medicine Overview
  • 11.11.3 Hengrui Medicine Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Hengrui Medicine Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Hengrui Medicine Recent Developments
• 11.12 Purity Pharmaceutical
  • 11.12.1 Purity Pharmaceutical Company Information
  • 11.12.2 Purity Pharmaceutical Overview
  • 11.12.3 Purity Pharmaceutical Orally Inhaled Generic Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Purity Pharmaceutical Orally Inhaled Generic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Purity Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Orally Inhaled Generic Drugs Industry Chain Analysis
• 12.2 Orally Inhaled Generic Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Orally Inhaled Generic Drugs Production Mode & Process
• 12.4 Orally Inhaled Generic Drugs Sales and Marketing
  • 12.4.1 Orally Inhaled Generic Drugs Sales Channels
  • 12.4.2 Orally Inhaled Generic Drugs Distributors
• 12.5 Orally Inhaled Generic Drugs Customers

13 Orally Inhaled Generic Drugs Market Dynamics

• 13.1 Orally Inhaled Generic Drugs Industry Trends
• 13.2 Orally Inhaled Generic Drugs Market Drivers
• 13.3 Orally Inhaled Generic Drugs Market Challenges
• 13.4 Orally Inhaled Generic Drugs Market Restraints

14 Key Findings in the Global Orally Inhaled Generic Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer